Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeoGenomics

9.83
+0.30503.20%
Post-market: 9.830.00000.00%17:23 EDT
Volume:1.18M
Turnover:11.65M
Market Cap:1.26B
PE:-15.81
High:9.99
Open:9.68
Low:9.60
Close:9.52
Loading ...

NEO Battery Materials Grants Incentive Stock Options to Leadership

TIPRANKS
·
Yesterday

Labcorp is Set to Acquire Select Assets of BioReference Health of OPK

Zacks
·
14 Mar

Global Hiring Intentions Hold Steady for Q2 2025 as Employers Continue to Navigate Uncertainty

PR Newswire
·
11 Mar

NeoGenomics’ Strategic Acquisition of Pathline: A Low-Risk Investment for Market Expansion and Growth

TIPRANKS
·
10 Mar

NeoGenomics Acquires Pathline

MT Newswires Live
·
10 Mar

BRIEF-NeoGenomics Expands Oncology Testing Reach In The Northeast With Acquisition Of Pathline

Reuters
·
10 Mar

Neogenomics Expands Oncology Testing Reach in the Northeast With Acquisition of Pathline

THOMSON REUTERS
·
10 Mar

Neogenomics Inc: Synergies From Transaction Expected to Yield Annual Cost Reductions, Which Will Be Accretive to Aebitda Starting in 2026

THOMSON REUTERS
·
10 Mar

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

Business Wire
·
10 Mar

3 Healthcare Stocks Skating on Thin Ice

StockStory
·
28 Feb

NeoGenomics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
27 Feb

NeoGenomics price target lowered to $18 from $21 at Piper Sandler

TIPRANKS
·
26 Feb

NeoGenomics to Participate in Upcoming Investor Conferences

Business Wire
·
24 Feb

NeoGenomics: Strong Core Business and Growth Catalysts Justify Buy Rating Despite Challenges

TIPRANKS
·
20 Feb

NeoGenomics price target lowered to $17 from $18 at BTIG

TIPRANKS
·
20 Feb

Stock Track | NeoGenomics Stock Soars 5.2% on Strong Q4 Revenue and Clinical Growth

Stock Track
·
20 Feb